The advances on the knowledge base of obesity and future therapeutic directions

Eat Weight Disord. 2001 Sep;6(3 Suppl):40-3.

Authors

R Vettor¹, C Pagano, G Federspil

Affiliation

¹ Department of Medical and Surgical Sciences, University of Padua, Padua, Italy.

PMID: 11706508

No abstract available

Publication types

Review

MeSH terms

Anti-Obesity Agents / adverse effects
Anti-Obesity Agents / therapeutic use*
Cyclobutanes / therapeutic use
Energy Metabolism*
Humans
Lactones / therapeutic use
Neuropeptides / agonists
Neuropeptides / antagonists & inhibitors
Obesity / drug therapy*
Obesity / physiopathology
Orlistat

Substances

Anti-Obesity Agents
Cyclobutanes
Lactones
Neuropeptides
Orlistat
sibutramine